The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) study

Author: Didangelos T.P.   Thanopoulou A.K.   Bousboulas S.H.   Sambanis C.L.   Athyros V.G.   Spanou E.A.   Dimitriou K.C.   Pappas S.I.   Karamanos B.G.   Karamitsos D.T.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.20, Iss.9, 2004-09, pp. : 1393-1401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content